Drug modifications: graphene oxide-chitosan loading enhanced anti-amoebic effects of pentamidine and doxycycline

Tooba Jabri1, Meshal Daalah2, Bader S Alawfi3

  • 1International Center for Chemical and Biological Sciences, H. E. J. Research Institute of Chemistry, University of Karachi, Karachi, 75270, Pakistan.

Parasitology Research
|November 20, 2024
PubMed

Insights

Modified doxycycline loaded onto chitosan-functionalized graphene oxide shows potent anti-Acanthamoeba effects. This nanotechnology approach effectively inhibits parasite growth and cyst formation without harming human cells, offering a promising new therapy for Acanthamoeba infections.

Area of Science:

  • Nanotechnology
  • Infectious Diseases
  • Parasitology

Background:

  • Acanthamoeba castellanii causes severe keratitis and encephalitis.
  • Current treatments for Acanthamoeba infections are limited, especially against the cyst stage.
  • Drug modification and nanotechnology offer potential solutions for neglected parasitic infections.

Purpose of the Study:

  • To investigate the enhanced anti-amoebic effects of pentamidine and doxycycline modified with chitosan-functionalized graphene oxide.
  • To evaluate the efficacy of these nanoconjugates against pathogenic Acanthamoeba castellanii (T4 genotype).
  • To assess the safety of these formulations on human cells.

Main Methods:

  • Preparation and characterization of chitosan-functionalized graphene oxide loaded with doxycycline and pentamidine.
  • Amoebicidal assays to determine efficacy against Acanthamoeba castellanii.
  • Lactate dehydrogenase assays to evaluate cytotoxicity against human cells.
  • Inhibition assays for excystation and encystation.

Main Results:

  • Chitosan-functionalized graphene oxide loaded with doxycycline exhibited significant amoebicidal activity.
  • The nanomaterial formulation effectively inhibited Acanthamoeba castellanii excystation and encystation (p < 0.05).
  • The tested nanoconjugates showed no significant toxicity to human cells in a concentration-dependent manner.

Conclusions:

  • Drug modification combined with nanotechnology presents a viable strategy for developing effective Acanthamoeba infection therapies.
  • Chitosan-functionalized graphene oxide loaded with doxycycline is a promising candidate for treating Acanthamoeba infections.
  • This approach offers a potential solution to overcome the limitations of current treatments, particularly against resistant parasite stages.